Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian N Fleming

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Organic & Biomolecular Chemistry|February 25, 2016
Enzymatic transhalogenation of dendritic RGD peptide constructs with the fluorinaseStephen Thompson, Ian N Fleming, David O'Hagan
Insights Into Imaging|July 2, 2021
Clinical value of 3'-deoxy-3'-[<sup>18</sup>F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancerBandar Alwadani, Sergio Dall'Angelo, Ian N Fleming
Nuclear Medicine Communications|December 8, 2011
Hypoxia imaging with PET: which tracers and why?Kazumi Chia, Ian N Fleming, Philip J Blower
Nuclear Medicine and Biology|June 22, 2013
Hypoxia stimulates 18F-fluorodeoxyglucose uptake in breast cancer cells via hypoxia inducible factor-1 and AMP-activated protein kinaseTim A D Smith, Matteo Zanda, Ian N Fleming
Nuclear Medicine Communications|December 2, 2010
Beyond 18F-fluorodeoxyglucose: making the next generation of PET radiotracers available for oncology research in the UKFiona Jane Gilbert, Ian N Fleming, Paul K Marsden
Nuclear Medicine Communications|September 28, 2011
Building PET research collaborationsIan N Fleming, Fiona J Gilbert, Philip J Blower
Breast Cancer Research and Treatment|February 14, 2014
Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1αIan N Fleming, Alexandra Andriu, Tim A D Smith
The Biochemical Journal|February 11, 2004
Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cellsIan H Batty, Ian N Fleming, C Peter Downes
Cell Death & Disease|November 15, 2019
A role for spinal cord hypoxia in neurodegenerationElena Hernandez-Gerez, Ian N Fleming, Simon H Parson
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 8, 2010
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigmIan N Fleming, Fiona J Gilbert, Ken A Miles, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Organic & Biomolecular Chemistry|February 25, 2016
Enzymatic transhalogenation of dendritic RGD peptide constructs with the fluorinaseStephen Thompson, Ian N Fleming, David O'Hagan
Insights Into Imaging|July 2, 2021
Clinical value of 3'-deoxy-3'-[<sup>18</sup>F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancerBandar Alwadani, Sergio Dall'Angelo, Ian N Fleming
Nuclear Medicine Communications|December 8, 2011
Hypoxia imaging with PET: which tracers and why?Kazumi Chia, Ian N Fleming, Philip J Blower
Nuclear Medicine and Biology|June 22, 2013
Hypoxia stimulates 18F-fluorodeoxyglucose uptake in breast cancer cells via hypoxia inducible factor-1 and AMP-activated protein kinaseTim A D Smith, Matteo Zanda, Ian N Fleming
Nuclear Medicine Communications|December 2, 2010
Beyond 18F-fluorodeoxyglucose: making the next generation of PET radiotracers available for oncology research in the UKFiona Jane Gilbert, Ian N Fleming, Paul K Marsden
Nuclear Medicine Communications|September 28, 2011
Building PET research collaborationsIan N Fleming, Fiona J Gilbert, Philip J Blower
Breast Cancer Research and Treatment|February 14, 2014
Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1αIan N Fleming, Alexandra Andriu, Tim A D Smith
The Biochemical Journal|February 11, 2004
Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cellsIan H Batty, Ian N Fleming, C Peter Downes
Cell Death & Disease|November 15, 2019
A role for spinal cord hypoxia in neurodegenerationElena Hernandez-Gerez, Ian N Fleming, Simon H Parson
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 8, 2010
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigmIan N Fleming, Fiona J Gilbert, Ken A Miles, et al.
Pageof 3